546 related articles for article (PubMed ID: 23664559)
1. Methotrexate therapy may prevent the onset of uveitis in juvenile idiopathic arthritis.
Papadopoulou C; Kostik M; Böhm M; Nieto-Gonzalez JC; Gonzalez-Fernandez MI; Pistorio A; Martini A; Ravelli A
J Pediatr; 2013 Sep; 163(3):879-84. PubMed ID: 23664559
[TBL] [Abstract][Full Text] [Related]
2. Methotrexate treatment may prevent uveitis onset in patients with juvenile idiopathic arthritis: experiences and subgroup analysis in a cohort with frequent methotrexate use.
Kostik MM; Gaidar EV; Hynnes AY; Dubko MF; Masalova VV; Snegireva LS; Chikova IA; Isupova EA; Nikitina TN; Serogodskaya ED; Kalashnikova OV; Ravelli A; Chasnyk VG
Clin Exp Rheumatol; 2016; 34(4):714-8. PubMed ID: 27385618
[TBL] [Abstract][Full Text] [Related]
3. Methotrexate is an effective treatment for chronic uveitis associated with juvenile idiopathic arthritis.
Foeldvari I; Wierk A
J Rheumatol; 2005 Feb; 32(2):362-5. PubMed ID: 15693100
[TBL] [Abstract][Full Text] [Related]
4. Leflunomide is associated with a higher flare rate compared to methotrexate in the treatment of chronic uveitis in juvenile idiopathic arthritis.
Bichler J; Benseler SM; Krumrey-Langkammerer M; Haas JP; Hügle B
Scand J Rheumatol; 2015; 44(4):280-3. PubMed ID: 25993023
[TBL] [Abstract][Full Text] [Related]
5. The role of subcutaneous administration of methotrexate in children with juvenile idiopathic arthritis who have failed oral methotrexate.
Alsufyani K; Ortiz-Alvarez O; Cabral DA; Tucker LB; Petty RE; Malleson PN
J Rheumatol; 2004 Jan; 31(1):179-82. PubMed ID: 14705239
[TBL] [Abstract][Full Text] [Related]
6. Impact of Antiinflammatory Treatment on the Onset of Uveitis in Juvenile Idiopathic Arthritis: Longitudinal Analysis From a Nationwide Pediatric Rheumatology Database.
Tappeiner C; Schenck S; Niewerth M; Heiligenhaus A; Minden K; Klotsche J
Arthritis Care Res (Hoboken); 2016 Jan; 68(1):46-54. PubMed ID: 26212111
[TBL] [Abstract][Full Text] [Related]
7. Delineating the role of multiple intraarticular corticosteroid injections in the management of juvenile idiopathic arthritis in the biologic era.
Papadopoulou C; Kostik M; Gonzalez-Fernandez MI; Bohm M; Nieto-Gonzalez JC; Pistorio A; Lanni S; Consolaro A; Martini A; Ravelli A
Arthritis Care Res (Hoboken); 2013 Jul; 65(7):1112-20. PubMed ID: 23335483
[TBL] [Abstract][Full Text] [Related]
8. Predictors of poor response to methotrexate in polyarticular-course juvenile idiopathic arthritis: analysis of the PRINTO methotrexate trial.
Vilca I; Munitis PG; Pistorio A; Ravelli A; Buoncompagni A; Bica B; Campos L; Häfner R; Hofer M; Ozen S; Huemer C; Bae SC; Sztajnbok F; Arguedas O; Foeldvari I; Huppertz HI; Gamir ML; Magnusson B; Dressler F; Uziel Y; van Rossum MA; Hollingworth P; Cawkwell G; Martini A; Ruperto N;
Ann Rheum Dis; 2010 Aug; 69(8):1479-83. PubMed ID: 20525842
[TBL] [Abstract][Full Text] [Related]
9. Adalimumab in combination with methotrexate for refractory uveitis associated with juvenile idiopathic arthritis: a RCT.
Ramanan AV; Dick AD; Jones AP; Hughes DA; McKay A; Rosala-Hallas A; Williamson PR; Hardwick B; Hickey H; Rainford N; Hickey G; Kolamunnage-Dona R; Culeddu G; Plumpton C; Wood E; Compeyrot-Lacassagne S; Woo P; Edelsten C; Beresford MW
Health Technol Assess; 2019 Apr; 23(15):1-140. PubMed ID: 31033434
[TBL] [Abstract][Full Text] [Related]
10. Serum osteopontin as a predictive marker of responsiveness to methotrexate in juvenile idiopathic arthritis.
Masi L; Ricci L; Zulian F; Del Monte F; Simonini G; Capannini S; De Martino M; Brandi ML; Falcini F
J Rheumatol; 2009 Oct; 36(10):2308-13. PubMed ID: 19684155
[TBL] [Abstract][Full Text] [Related]
11. Prevalence, risk factors, and outcome of uveitis in juvenile idiopathic arthritis: a long-term followup study.
Saurenmann RK; Levin AV; Feldman BM; Rose JB; Laxer RM; Schneider R; Silverman ED
Arthritis Rheum; 2007 Feb; 56(2):647-57. PubMed ID: 17265500
[TBL] [Abstract][Full Text] [Related]
12. Analysis of intracellular methotrexate polyglutamates in patients with juvenile idiopathic arthritis: effect of route of administration on variability in intracellular methotrexate polyglutamate concentrations.
Becker ML; van Haandel L; Gaedigk R; Lasky A; Hoeltzel M; Stobaugh J; Leeder JS
Arthritis Rheum; 2010 Jun; 62(6):1803-12. PubMed ID: 20191581
[TBL] [Abstract][Full Text] [Related]
13. Time to treatment as an important factor for the response to methotrexate in juvenile idiopathic arthritis.
Albers HM; Wessels JA; van der Straaten RJ; Brinkman DM; Suijlekom-Smit LW; Kamphuis SS; Girschick HJ; Wouters C; Schilham MW; le Cessie S; Huizinga TW; Ten Cate R; Guchelaar HJ
Arthritis Rheum; 2009 Jan; 61(1):46-51. PubMed ID: 19116975
[TBL] [Abstract][Full Text] [Related]
14. Uveitis Events During Adalimumab, Etanercept, and Methotrexate Therapy in Juvenile Idiopathic Arthritis: Data From the Biologics in Pediatric Rheumatology Registry.
Foeldvari I; Becker I; Horneff G
Arthritis Care Res (Hoboken); 2015 Nov; 67(11):1529-35. PubMed ID: 25988824
[TBL] [Abstract][Full Text] [Related]
15. Visual outcomes in children with juvenile idiopathic arthritis-associated uveitis.
Kump LI; Castañeda RA; Androudi SN; Reed GF; Foster CS
Ophthalmology; 2006 Oct; 113(10):1874-7. PubMed ID: 16884776
[TBL] [Abstract][Full Text] [Related]
16. Surgery for hypotony in patients with juvenile idiopathic arthritis-associated uveitis.
Yu EN; Paredes I; Foster CS
Ocul Immunol Inflamm; 2007; 15(1):11-7. PubMed ID: 17365801
[TBL] [Abstract][Full Text] [Related]
17. Safety and efficacy of infliximab and adalimumab for refractory uveitis in juvenile idiopathic arthritis: 1-year followup data from the Italian Registry.
Zannin ME; Birolo C; Gerloni VM; Miserocchi E; Pontikaki I; Paroli MP; Bracaglia C; Shardlow A; Parentin F; Cimaz R; Simonini G; Falcini F; Corona F; Viola S; De Marco R; Breda L; La Torre F; Vittadello F; Martini G; Zulian F
J Rheumatol; 2013 Jan; 40(1):74-9. PubMed ID: 23118110
[TBL] [Abstract][Full Text] [Related]
18. Frequency of relapse after discontinuation of methotrexate therapy for clinical remission in juvenile rheumatoid arthritis.
Ravelli A; Viola S; Ramenghi B; Aramini L; Ruperto N; Martini A
J Rheumatol; 1995 Aug; 22(8):1574-6. PubMed ID: 7473486
[TBL] [Abstract][Full Text] [Related]
19. The magnitude of early response to methotrexate therapy predicts long-term outcome of patients with juvenile idiopathic arthritis.
Bartoli M; Tarò M; Magni-Manzoni S; Pistorio A; Traverso F; Viola S; Magnani A; Gasparini C; Martini A; Ravelli A
Ann Rheum Dis; 2008 Mar; 67(3):370-4. PubMed ID: 17660217
[TBL] [Abstract][Full Text] [Related]
20. Prevalence and outcome of juvenile idiopathic arthritis-associated uveitis and relation to articular disease.
Grassi A; Corona F; Casellato A; Carnelli V; Bardare M
J Rheumatol; 2007 May; 34(5):1139-45. PubMed ID: 17343317
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
